Respiratory infection complicating HIV infection
- PMID: 18317044
- PMCID: PMC2636795
- DOI: 10.1097/QCO.0b013e3282f54fff
Respiratory infection complicating HIV infection
Abstract
Purpose of review: Respiratory infections remain a major cause of morbidity among HIV-infected persons. Thus, knowledge of recent advances regarding HIV-associated opportunistic pneumonias is crucial for optimal care of HIV-infected persons.
Recent findings: Bacterial pneumonia is the most common HIV-associated opportunistic pneumonia in the USA and its incidence remains appreciable. Worldwide, tuberculosis dominates the clinical picture. The absence of rapid, affordable diagnostics for active and latent tuberculosis remains a major obstacle that must be overcome if the global epidemic is to be slowed. The specter of extensively drug resistant tuberculosis and its overlap with HIV infection highlight the importance of rapid diagnostics and the need for accessible drug susceptibility testing. Pneumocystis (carinii) jirovecii pneumonia appears to be a more common pneumonia among HIV-infected persons residing in developing countries than was previously appreciated. Similar to tuberculosis, the absence of available diagnostics in developing areas is a major obstacle to clinical care and epidemiologic studies. The critical care of HIV-infected persons is challenging.
Summary: Although tremendous advances have been made in our understanding of the management, treatment, and prevention of HIV and its associated respiratory infections, significant gaps remain. Thus, continued epidemiologic, clinical, and bench research is needed.
References
-
- Kohli R, Lo Y, Homel P, et al. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis. 2006;43:90–8. *The rate of bacterial pneumonia in HIV-infected women remains extremely high despite the introduction of ART. - PubMed
-
- Penaranda M, Falco V, Payeras A, et al. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Clin Infect Dis. 2007;45:e82–7. *A case control study that identified ART and the polysaccharide pneumococcal vaccine as independently lowering the risk of pneumococcal infection, even in patients with a CD4 count less than 200 cells/μL. - PubMed
-
- Flannery B, Heffernan RT, Harrison LH, et al. Changes in invasive Pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Intern Med. 2006;144:1–9. *A cohort study suggesting that the introduction of the pediatric pneumococccal conjugate vaccine has decreased the rate of invasive pneumococcal disease in HIV-infected adults. - PubMed
-
- Klein MB, Lu Y, DelBalso L, et al. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis. 2007;45:234–40. *Influenza is a common cause of febrile respiratory symptoms in HIV-infected patients on ART presenting to an outpatient clinic for care despite high rates of prior influenza vaccination. - PubMed
-
- Getahun H, Harrington M, O’Brien R, et al. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet. 2007;369:2042–9. *A compelling argument for modification of national TB evaluation algorithms. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
